Commentary: Increased CDC6 Expression Associates With Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma.
作者信息
Temiz Mustafa Zafer
机构信息
Department of Urology, Bagcilar Training and Research Hospital, Istanbul, Turkey.
出版信息
Front Oncol. 2021 Oct 5;11:730782. doi: 10.3389/fonc.2021.730782. eCollection 2021.
Abstract
摘要
相似文献
1
Commentary: Increased CDC6 Expression Associates With Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma.
Front Oncol. 2021 Oct 5;11:730782. doi: 10.3389/fonc.2021.730782. eCollection 2021.
2
Corrigendum: Increased CDC6 Expression Associates With Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma.
Front Oncol. 2021 Jul 21;11:731942. doi: 10.3389/fonc.2021.731942. eCollection 2021.
3
High expression of CDC6 is associated with accelerated cell proliferation and poor prognosis of epithelial ovarian cancer.
Pathol Res Pract. 2016 Apr;212(4):239-46. doi: 10.1016/j.prp.2015.09.014. Epub 2015 Sep 18.
4
Expression of CDC6 and GDF-9 and their clinicopathological significances in benign and malignant lesions of the gallbladder.
Cancer Biomark. 2012;11(2-3):107-14. doi: 10.3233/CBM-2012-0267.
5
CDC6 is a possible biomarker for hepatocellular carcinoma.
Int J Clin Exp Pathol. 2021 Jul 15;14(7):811-818. eCollection 2021.
6
CDC6 is up-regulated and a poor prognostic signature in glioblastoma multiforme.
Clin Transl Oncol. 2021 Mar;23(3):565-571. doi: 10.1007/s12094-020-02449-w. Epub 2020 Jul 13.
7
[Expression and clinical significance of CDC6 and hMSH2 in cervical carcinoma].
Sichuan Da Xue Xue Bao Yi Xue Ban. 2009 Sep;40(5):857-60.
8
The prognostic significance of Cdc6 and Cdt1 in breast cancer.
Sci Rep. 2017 Apr 20;7(1):985. doi: 10.1038/s41598-017-00998-9.
9
Beta-1,4-galactosyltransferase II predicts poor prognosis of patients with non-metastatic clear-cell renal cell carcinoma.
Tumour Biol. 2017 Feb;39(2):1010428317691417. doi: 10.1177/1010428317691417.
10
MicroRNA-155 is a predictive marker for survival in patients with clear cell renal cell carcinoma.
Int J Urol. 2013 May;20(5):468-77. doi: 10.1111/j.1442-2042.2012.03182.x. Epub 2012 Oct 10.
引用本文的文献
1
Comprehensive analysis pinpoints CCNA2 as a prognostic and immunological biomarker in non-small cell lung cancer.
BMC Pulm Med. 2025 Jan 11;25(1):14. doi: 10.1186/s12890-025-03490-7.
本文引用的文献
1
Increased CDC6 Expression Associates With Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma.
Front Oncol. 2021 May 24;11:666418. doi: 10.3389/fonc.2021.666418. eCollection 2021.
2
Urologic malignancies: advances in the analysis and interpretation of clinical findings.
Future Sci OA. 2021 Feb 4;7(4):FSO674. doi: 10.2144/fsoa-2020-0210.
3
Tumor volume: a new prognostic factor of oncological outcome of localized clear cell renal cell carcinoma.
BMC Cancer. 2021 Jan 19;21(1):79. doi: 10.1186/s12885-021-07795-8.
4
Novel Blood Indicators of Progression and Prognosis in Renal Cell Carcinoma: Red Cell Distribution Width-to-Lymphocyte Ratio and Albumin-to-Fibrinogen Ratio.
J Oncol. 2020 Nov 25;2020:2895150. doi: 10.1155/2020/2895150. eCollection 2020.
5
The Predictive Value of Programmed Death Ligand 1 in Patients with Metastatic Renal Cell Carcinoma Treated with Immune-checkpoint Inhibitors: A Systematic Review and Meta-analysis.
Eur Urol. 2021 Jun;79(6):783-792. doi: 10.1016/j.eururo.2020.10.006. Epub 2020 Nov 7.
6
Prognostication in Kidney Cancer: Recent Advances and Future Directions.
J Clin Oncol. 2018 Oct 29:JCO2018790147. doi: 10.1200/JCO.2018.79.0147.
7
WHO/ISUP classification, grading and pathological staging of renal cell carcinoma: standards and controversies.
World J Urol. 2018 Dec;36(12):1913-1926. doi: 10.1007/s00345-018-2447-8. Epub 2018 Aug 19.
8
Predictive value of inflammation-based prognostic scores in patients with metastatic renal cell carcinoma treated with cytoreductive nephrectomy.
Oncotarget. 2018 Feb 16;9(18):14296-14305. doi: 10.18632/oncotarget.24507. eCollection 2018 Mar 6.
9
Prognostic role of the neutrophil-lymphocyte ratio in renal cell carcinoma: a meta-analysis.
BMJ Open. 2015 Apr 8;5(4):e006404. doi: 10.1136/bmjopen-2014-006404.
10
The post-operative pathological prognostic parameters of clear cell renal cell carcinoma in pT1a cases.
Pathol Int. 2011 Mar;61(3):116-21. doi: 10.1111/j.1440-1827.2010.02633.x. Epub 2011 Jan 9.
Zotero 插件